Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

248
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
248
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

281
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
281
Hepatic Portal System01:21

Hepatic Portal System

6.1K
The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
6.1K
Hepatic Drug Excretion: Influencing Factors01:16

Hepatic Drug Excretion: Influencing Factors

597
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
597
Hepatic Drug Clearance: Role of Transporters01:14

Hepatic Drug Clearance: Role of Transporters

311
In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
311
Hepatic Drug Excretion: Enterohepatic Cycling01:17

Hepatic Drug Excretion: Enterohepatic Cycling

2.8K
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
2.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fluid and electrolyte problems in clinical medicine.

School of Medicine. University of Southern California. School of Medicine·2014
Same author

The relationship of JAK2(V617F) and acquired UPD at chromosome 9p in polycythemia vera.

Leukemia·2014
Same author

Whole-exome sequencing of polycythemia vera revealed novel driver genes and somatic mutation shared by T cells and granulocytes.

Leukemia·2014
Same author

Deep resequencing and association analysis of schizophrenia candidate genes.

Molecular psychiatry·2012
Same author

[Hypoplastic anemia with immaturity of the marrow].

Annals of western medicine and surgery·2010
Same author

Necrosis of renal papillae and acute pyelonephritis in diabetes mellitus.

Archives of internal medicine (Chicago, Ill. : 1908)·2010
Same journal

Clinicopathologic and Molecular Analysis of Traditional Serrated Adenoma and Its Possible Precursor Lesions With Special Reference to RSPO Fusion Status: A Large Case Series From Single Institution.

The American journal of surgical pathology·2026
Same journal

NF2/Merlin Immunohistochemistry Helps Distinguish Collecting Duct Carcinoma From Upper Tract Urothelial Carcinoma.

The American journal of surgical pathology·2026
Same journal

Neuroendocrine Carcinoma of the Gallbladder: Clinicopathologic and Immunohistochemical Analysis of 31 Cases.

The American journal of surgical pathology·2026
Same journal

Papillary Renal Neoplasm With Reverse Polarity Is a Distinct Distal Nephron-Derived Tumor With Unique Methylation Profile.

The American journal of surgical pathology·2026
Same journal

Biallelic ARID1A Alterations: A Promising Novel Biomarker for Risk Stratification and Management in Pediatric Malignant Hepatocellular Tumors.

The American journal of surgical pathology·2026
Same journal

Absent Cyclin D1 Expression in Myeloid Sarcomas Distinguishes From Malignant Histiocytic Neoplasms: When Morphologic Ambiguity is Deceptive.

The American journal of surgical pathology·2026
See all related articles

Related Experiment Video

Updated: Feb 9, 2026

Endoscopic Approach for Colloid Cyst Resection
02:30

Endoscopic Approach for Colloid Cyst Resection

Published on: May 23, 2025

824

Ciliated hepatic foregut cyst.

D A Wheeler, H A Edmondson

    The American Journal of Surgical Pathology
    |June 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    A rare ciliated hepatic cyst, histologically similar to bronchial and esophageal cysts, was identified. This finding suggests these cysts may originate from the embryonic foregut, expanding our understanding of hepatic cyst origins.

    More Related Videos

    Author Spotlight: Recent Advancements in Reoperative Foregut Surgery
    04:14

    Author Spotlight: Recent Advancements in Reoperative Foregut Surgery

    Published on: September 22, 2023

    942
    Microscopic Cyst Resection for the Treatment of Patients Diagnosed with Epididymal Cyst
    03:10

    Microscopic Cyst Resection for the Treatment of Patients Diagnosed with Epididymal Cyst

    Published on: March 31, 2023

    12.2K

    Related Experiment Videos

    Last Updated: Feb 9, 2026

    Endoscopic Approach for Colloid Cyst Resection
    02:30

    Endoscopic Approach for Colloid Cyst Resection

    Published on: May 23, 2025

    824
    Author Spotlight: Recent Advancements in Reoperative Foregut Surgery
    04:14

    Author Spotlight: Recent Advancements in Reoperative Foregut Surgery

    Published on: September 22, 2023

    942
    Microscopic Cyst Resection for the Treatment of Patients Diagnosed with Epididymal Cyst
    03:10

    Microscopic Cyst Resection for the Treatment of Patients Diagnosed with Epididymal Cyst

    Published on: March 31, 2023

    12.2K

    Area of Science:

    • Gastroenterology
    • Histopathology
    • Embryology

    Background:

    • Liver cysts are uncommon, with diverse origins and histological presentations.
    • Biliary cystadenomas are a known type of intrahepatic cystic lesion.

    Observation:

    • A solitary unilocular liver cyst was characterized.
    • The cyst lining featured ciliated, pseudostratified, columnar epithelium.
    • A smooth muscle layer and fibrous capsule composed the cyst wall.

    Findings:

    • The histological features differentiated the cyst from biliary cystadenoma.
    • The cyst's histology closely resembled ciliated bronchial and esophageal cysts.
    • This suggests a shared origin from the embryonic foregut for these cyst types.

    Implications:

    • This study introduces the concept of ciliated hepatic cysts, previously unrecognized in the liver.
    • It proposes a unified spectrum for foregut-derived cysts, including hepatic, bronchial, and esophageal.
    • This expands the differential diagnosis for liver cystic lesions.